China · Delayed Price · Currency is CNY Cowealth Medical China Statistics
Total Valuation
SHA:603122 has a market cap or net worth of CNY 5.56 billion. The enterprise value is 5.46 billion.
| Market Cap | 5.56B |
| Enterprise Value | 5.46B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | Jul 14, 2025 |
Share Statistics
SHA:603122 has 398.05 million shares outstanding. The number of shares has increased by 8.98% in one year.
| Current Share Class | 398.05M |
| Shares Outstanding | 398.05M |
| Shares Change (YoY) | +8.98% |
| Shares Change (QoQ) | -18.97% |
| Owned by Insiders (%) | 1.73% |
| Owned by Institutions (%) | 1.54% |
| Float | 172.39M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.58 |
| PB Ratio | 5.35 |
| P/TBV Ratio | 5.39 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.42 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.96, with a Debt / Equity ratio of 0.03.
| Current Ratio | 2.96 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.47 |
| Interest Coverage | -16.70 |
Financial Efficiency
Return on equity (ROE) is -3.13% and return on invested capital (ROIC) is -4.09%.
| Return on Equity (ROE) | -3.13% |
| Return on Assets (ROA) | -1.65% |
| Return on Invested Capital (ROIC) | -4.09% |
| Return on Capital Employed (ROCE) | -3.85% |
| Weighted Average Cost of Capital (WACC) | 3.43% |
| Revenue Per Employee | 4.03M |
| Profits Per Employee | -209,963 |
| Employee Count | 161 |
| Asset Turnover | 0.43 |
| Inventory Turnover | 3.07 |
Taxes
| Income Tax | -5.47M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +103.89% in the last 52 weeks. The beta is -0.15, so SHA:603122's price volatility has been lower than the market average.
| Beta (5Y) | -0.15 |
| 52-Week Price Change | +103.89% |
| 50-Day Moving Average | 11.82 |
| 200-Day Moving Average | 16.00 |
| Relative Strength Index (RSI) | 61.18 |
| Average Volume (20 Days) | 31,175,861 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603122 had revenue of CNY 648.86 million and -33.80 million in losses. Loss per share was -0.08.
| Revenue | 648.86M |
| Gross Profit | 95.47M |
| Operating Income | -40.06M |
| Pretax Income | -39.19M |
| Net Income | -33.80M |
| EBITDA | -33.66M |
| EBIT | -40.06M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 137.90 million in cash and 31.41 million in debt, with a net cash position of 106.49 million or 0.27 per share.
| Cash & Cash Equivalents | 137.90M |
| Total Debt | 31.41M |
| Net Cash | 106.49M |
| Net Cash Per Share | 0.27 |
| Equity (Book Value) | 1.04B |
| Book Value Per Share | 2.61 |
| Working Capital | 750.09M |
Cash Flow
In the last 12 months, operating cash flow was -54.82 million and capital expenditures -12.27 million, giving a free cash flow of -67.09 million.
| Operating Cash Flow | -54.82M |
| Capital Expenditures | -12.27M |
| Depreciation & Amortization | 6.39M |
| Net Borrowing | -4.53M |
| Free Cash Flow | -67.09M |
| FCF Per Share | -0.17 |
Margins
Gross margin is 14.71%, with operating and profit margins of -6.17% and -5.21%.
| Gross Margin | 14.71% |
| Operating Margin | -6.17% |
| Pretax Margin | -6.04% |
| Profit Margin | -5.21% |
| EBITDA Margin | -5.19% |
| EBIT Margin | -6.17% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 0.93%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 0.93% |
| Dividend Growth (YoY) | 116.67% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.98% |
| Shareholder Yield | -8.05% |
| Earnings Yield | -0.61% |
| FCF Yield | -1.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603122 has an Altman Z-Score of 9.83 and a Piotroski F-Score of 2.
| Altman Z-Score | 9.83 |
| Piotroski F-Score | 2 |